As a result, we identified a 20-gene signature (ANAPC1, BTBD7, CA11, CYB561D2, DRD5, FKBP6, HOXC10, LAMB4, LOC101928747, PADI1, PAX3, PF4, PYGM, QPCTL, RPL36A, RPS4XP2, SLC18A1, TP53TG3, USB1, ZNF280A in Supplementary Table 1) that was associated with radiotherapy in gliomas. Here, RPL36A is linked to central nervous system cancer.